Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution…
Commercial
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief…
Commercial
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 –…
Clinical
The European Commission has Granted Orphan Medicinal Product Designation in the…
Clinical
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study…
Clinical
Discovery of new step in how brain cells work could lead…
Home
Commercial
Acquisitions
Acquisitions
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Acquisitions
Dr. David G. Kallend joins DalCor Pharmaceuticals as Chief Scientific Officer
Globenewswire News
-
July 2, 2020
Acquisitions
Helsinn Group and MEI Pharma Discontinue the Phase 3 Study with Pracinostat in AML after Completing Interim Analysis
Acquisitions
Dr. David G. Kallend joins DalCor Pharmaceuticals as Chief Scientific Officer
Acquisitions
BioSpace Movers & Shakers, June 26
Acquisitions
Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol
Acquisitions
CSL Behring to Acquire Biotech Company Vitaeris
-
June 9, 2020
0
Acquisitions
Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan...
Firstwordpharma News
-
March 29, 2020
0
Acquisitions
Zyla Life Sciences Reports Fourth Quarter and Full Year 2019 Financial...
Firstwordpharma News
-
March 29, 2020
0
Acquisitions
Failed studies prompt Lundbeck to terminate foliglurax in Parkinson’s disease, Lu...
Firstwordpharma News
-
March 29, 2020
0
Acquisitions
Novartis new analysis further shows durable and potent LDL-C reduction with...
Globenewswire News
-
March 28, 2020
0
1
2
3
...
31
Page 1 of 31
- Advertisement -
MOST POPULAR
BIOCORP and SANOFI Strengthen Their Partnership With Mallya Smart Sensors
January 14, 2020
First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy,...
July 8, 2019
Ovid Therapeutics Announces Multiple Presentations at the American Academy of Neurology...
March 5, 2020
Dr. David G. Kallend joins DalCor Pharmaceuticals as Chief Scientific Officer
July 2, 2020
Load more
HOT NEWS
Clinical
Viracta Receives Orphan Drug Designation from the US FDA for its...
Others
Women’s History Month: Top Influential Women in Biopharma
Deals
Amgen Snaps Up Nuevolution in $167 Million Deal
Others
Teva Recalls More Tainted Blood Pressure Drugs
